Quantbot Technologies LP Kodiak Sciences Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.4 - $3.24 $11,200 - $25,920	8,000 Added 333.33%	10,400 $31,000
Q3 2023 Nov 07, 2023	BUY	$1.8 - $7.49 $4,320 - $17,976	2,400 New	2,400 $4,000
Q1 2023 May 12, 2023	BUY	$4.81 - $8.88 $18,759 - $34,632	3,900 Added 65.03%	9,897 $61,000
Q4 2022 Feb 13, 2023	SELL	$6.52 - $8.05 $47,622 - $58,797	-7,304 Reduced 54.91%	5,997 $42,000
Q3 2022 Nov 07, 2022	SELL	$7.57 - $12.5 $59,159 - $97,687	-7,815 Reduced 37.01%	13,301 $102,000
Q2 2022 Aug 09, 2022	BUY	$5.04 - $9.48 $106,424 - $200,179	21,116 New	21,116 $161,000
Q4 2021 Feb 11, 2022	SELL	$80.85 - $128.49 $234,464 - $372,621	-2,900 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$77.2 - $126.54 $223,880 - $366,966	2,900 New	2,900 $269,000
Q4 2020 Feb 12, 2021	SELL	$60.78 - $154.03 $12,156 - $30,806	-200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$45.05 - $59.27 $9,010 - $11,854	200 New	200 $11,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.